Glanzmann's disease: clinical elements and therapeutic behavior
Journal Title: Revista científica estudiantil 2 de Diciembre - Year 2022, Vol 5, Issue 1
Abstract
Introduction: Glanzmann's disease is a rare disorder, with a worldwide distribution that predominates in the Asian region; it has specific symptoms and emergent treatment. Objective: to describe the clinical elements and the therapeutic behavior of Glanzmann's disease. Method: a bibliographic review was carried out in the databases SciELO, Scopus, ClinicalKey and PubMed. The combination of terms was used as a search strategy, using the name of the disease, clinic and treatment. 21 references were selected. Development: there are three subtypes of Glanzmann's thrombasthenia. The clinical manifestations are variable and include mucocutaneous and gastrointestinal hemorrhages, presence of hemarthrosis, intracranial hemorrhage, and visceral hematoma. Prophylaxis is recommended before major surgeries and avoiding the use of drugs that affect platelet function such as non-steroidal anti-inflammatory drugs and aspirin. The only curative measure for patients with recurrent bleeding episodes or who are refractory to platelet transfusions is allogeneic hematopoietic cell transplantation. Conclusions: the clinical method that includes the search for history and a rigorous physical examination, accompanied by complementary tests, plays an important role in the diagnosis of rhombobastenia. In this way, therapeutics focuses on controlling acute symptoms and platelet transfusions, with several options such as gene therapy still under study; all in order to improve the quality of life and extend it.
Authors and Affiliations
Yurixán RodrÃguez Ãvila,Rodolfo Javier Rivero Morey,
Keywords
Related Articles
- EP ID EP702498
- DOI -
- Views 43
- Downloads 0
Clinical epidemiological behavior of pediatric patients with a diagnosis of arterial hypertension
Introduction: arterial hypertension at early ages is an important pathology that can lead to disorders in the normal development of infants and if not treated promptly can evolve to chronicity and trigger secondary patho...
Students from medical Sciences in preventive measures to COVID-19 in Bayamo
Introduction: COVID-19, a disease caused by the new coronavirus identified in China in December 2019, has been considered a pandemic, and its screening by medical students allows the detection of suspected and positive c...
Glanzmann's disease: clinical elements and therapeutic behavior
Introduction: Glanzmann's disease is a rare disorder, with a worldwide distribution that predominates in the Asian region; it has specific symptoms and emergent treatment. Objective: to describe the clinical elements and...
An observational study on bacterial infections in hospitalized coronavirus patients in a tertiary care center
Introduction: The latest global pandemic is caused by SARS-CoV-2 coronavirus. 6% of patients are admitted to the hospital, with 20% of those admitted to the intensive care unit (ICU) due to acute respiratory distress syn...
Myths and facts about the application of corticosteroids in patients diagnosed with COVID-19
The pandemic caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), the causative agent of COVID-19, has been spreading around the world for more than a year. Pathophysiologically, the virus infects hos...